Anteris Technologies Ltd. (AU:AVR) has released an update.
Anteris Technologies Ltd. has successfully raised $24.15 million through the issue of 1,115,000 new shares, leveraging their patented ADAPT tissue technology and innovative DurAVRTM heart valve. The company, known for its ground-breaking solutions in the structural heart disease space, issued shares without disclosure under certain provisions of the Corporations Act, highlighting compliance with the Act’s requirements and confirming the absence of undisclosed ‘excluded information’.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.
